Your search returned 1384 results.

Results
	1341.	Comparative study of biological activity of three commercial products of Sasa senanensis Rehder leaf extract. [electronic resource] by Sakagami, Hiroshi Iwamoto, Shoko Matsuta, Tomohiko Satoh, Kazue Shimada, Chiyako Kanamoto, Taisei Terakubo, Shigemi Nakashima, Hideki Morita, Yurika Ohkubo, Atsuko Tsuda, Tadashi Sunaga, Katsuyoshi Kitajima, Madoka Oizumi, Hiroshi Oizumi, Takaaki Producer: 20120625 In: In vivo (Athens, Greece) vol. 26 Availability: No items available. Save to lists Add to cart (remove)
	1342.	CYP3A4 genetic status may be associated with increased vulnerability to the inhibitory effect of calcium-channel blockers on clopidogrel. [electronic resource] by Park, Jin Joo Park, Kyung Woo Kang, Jeehoon Jeon, Ki-Hyun Kang, Si-Hyuck Ahn, Hyo Suk Han, Jung-Kyu Koh, Jin-Sin Lee, Sang Eun Yang, Han-Mo Lee, Hae-Young Kang, Hyun-Jae Koo, Bon-Kwon Oh, Byung-Hee Park, Young-Bae Kim, Hyo-Soo Producer: 20131031 In: Circulation journal : official journal of the Japanese Circulation Society vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1343.	Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A. [electronic resource] by Prueksaritanont, T Tatosian, D A Chu, X Railkar, R Evers, R Chavez-Eng, C Lutz, R Zeng, W Yabut, J Chan, G H Cai, X Latham, A H Hehman, J Stypinski, D Brejda, J Zhou, C Thornton, B Bateman, K P Fraser, I Stoch, S A Producer: 20170516 In: Clinical pharmacology and therapeutics vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1344.	[Pharmacogenomics in routine medical care]. [electronic resource] by Rosskopf, D Meyer zu Schwabedissen, H E Kroemer, H K Siegmund, W Producer: 20100201 In: Deutsche medizinische Wochenschrift (1946) vol. 135 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1345.	Mechanisms of pharmacokinetic enhancement between ritonavir and saquinavir; micro/small dosing tests using midazolam (CYP3A4), fexofenadine (p-glycoprotein), and pravastatin (OATP1B1) as probe drugs. [electronic resource] by Ieiri, Ichiro Tsunemitsu, Shyohei Maeda, Kazuya Ando, Yukie Izumi, Noritomo Kimura, Miyuki Yamane, Naoe Okuzono, Tsuyoshi Morishita, Mariko Kotani, Naoki Kanda, Eri Deguchi, Mariko Matsuguma, Kyoko Matsuki, Shunji Hirota, Takeshi Irie, Shin Kusuhara, Hiroyuki Sugiyama, Yuichi Producer: 20131210 In: Journal of clinical pharmacology vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1346.	Stereoselective evasion of P-glycoprotein, cytochrome P450 3A, and hydrolases by peptide prodrug modification of saquinavir. [electronic resource] by Wang, Zhiying Pal, Dhananjay Mitra, Ashim K Producer: 20121207 In: Journal of pharmaceutical sciences vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1347.	Multisite phosphorylation of human liver cytochrome P450 3A4 enhances Its gp78- and CHIP-mediated ubiquitination: a pivotal role of its Ser-478 residue in the gp78-catalyzed reaction. [electronic resource] by Wang, YongQiang Guan, Shenheng Acharya, Poulomi Liu, Yi Thirumaran, Ranjit K Brandman, Relly Schuetz, Erin G Burlingame, Alma L Correia, Maria Almira Producer: 20120601 In: Molecular & cellular proteomics : MCP vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1348.	Identification of human cytochrome P450 isoforms and esterases involved in the metabolism of mirabegron, a potent and selective β3-adrenoceptor agonist. [electronic resource] by Takusagawa, Shin Yajima, Kanako Miyashita, Aiji Uehara, Shotaro Iwatsubo, Takafumi Usui, Takashi Producer: 20130625 In: Xenobiotica; the fate of foreign compounds in biological systems vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1349.	In vitro-in vivo extrapolation of zolpidem as a perpetrator of metabolic interactions involving CYP3A. [electronic resource] by Polasek, Thomas M Sadagopal, Janani S Elliot, David J Miners, John O Producer: 20100506 In: European journal of clinical pharmacology vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1350.	RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity. [electronic resource] by Walubo, A Barr, S Abraham, A M Producer: 20070205 In: Methods and findings in experimental and clinical pharmacology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1351.	Inhibition of CYP3A4 expression by ketoconazole is mediated by the disruption of pregnane X receptor, steroid receptor coactivator-1, and hepatocyte nuclear factor 4alpha interaction. [electronic resource] by Lim, Yun-Ping Kuo, Sheng-Chun Lai, Ming-Liang Huang, Jin-Ding Producer: 20090303 In: Pharmacogenetics and genomics vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1352.	Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator. [electronic resource] by Jornil, Jakob Jensen, Klaus Gjervig Larsen, Frank Linnet, Kristian Producer: 20100602 In: Drug metabolism and disposition: the biological fate of chemicals vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1353.	A thorough QTc study of 3 doses of iloperidone including metabolic inhibition via CYP2D6 and/or CYP3A4 and a comparison to quetiapine and ziprasidone. [electronic resource] by Potkin, Steven G Preskorn, Sheldon Hochfeld, Marla Meng, Xiangyi Producer: 20130612 In: Journal of clinical psychopharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1354.	Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib. [electronic resource] by Mohamed, Mohamed-Eslam F Jungerwirth, Steven Asatryan, Armen Jiang, Ping Othman, Ahmed A Producer: 20180604 In: British journal of clinical pharmacology vol. 83 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1355.	Is there a place for drug combination strategies using clinical pharmacology attributes?--review of current trends in research. [electronic resource] by Srinivas, Nuggehally R Producer: 20091221 In: Current clinical pharmacology vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1356.	Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers. [electronic resource] by Tugnait, Meera Gupta, Neeraj Hanley, Michael J Sonnichsen, Daryl Kerstein, David Dorer, David J Venkatakrishnan, Karthik Narasimhan, Narayana Producer: 20210528 In: Clinical pharmacology in drug development vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1357.	In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors. [electronic resource] by Moody, David E Liu, Fenyun Fang, Wenfang B Producer: 20140414 In: Journal of analytical toxicology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1358.	Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. [electronic resource] by DiNardo, Courtney D Rausch, Caitlin R Benton, Christopher Kadia, Tapan Jain, Nitin Pemmaraju, Naveen Daver, Naval Covert, Wendy Marx, Kayleigh R Mace, Morgan Jabbour, Elias Cortes, Jorge Garcia-Manero, Guillermo Ravandi, Farhad Bhalla, Kapil N Kantarjian, Hagop Konopleva, Marina Producer: 20190425 In: American journal of hematology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1359.	Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipine. [electronic resource] by Li, Cheng Choi, Dong-Hyun Choi, Jun-Shik Producer: 20120927 In: Journal of pharmacokinetics and pharmacodynamics vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1360.	Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors. [electronic resource] by Yang, Si-Hyung Choi, Jun-Shik Choi, Dong-Hyun Producer: 20120325 In: Pharmacology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
59
60
61
62
63
64
65
66
67
68
69
70
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1384 results.